Xeris Pharmaceuticals



Ebitda Veränderung Datum
Celltrion KRW 284.19B 78.15B 2024-09
Cspc Pharmaceutical CNY 2.21B 275.77M 2023-12
Dianthus Therapeutics USD -29875000 7.69M 2024-09
Ecofibre AUD -3020000 428K 2024-06
Eli Lilly USD 6.17B 1.27B 2024-12
Kangmei Pharma -3262057.35 15.91M 2024-09
Knight Therapeutics CAD 16.72M 1.05M 2024-09
Laboratorios Farma EUR 44.28M 18.33M 2024-06
Malin Corporation EUR -1300000 900K 2024-06
Medical Developments International AUD -2000000 9.47M 2024-06
Neuren Pharmaceuticals AUD 176.7M 166.79M 2024-12
Organigram Holdings CAD -16179000 63.98M 2024-12
Pacira USD 50.78M 8.5M 2024-12
Perrigo USD 245.1M 49.4M 2024-12
Pharma Mar EUR 6.96M 87K 2024-12
Qiagen NV USD 177.93M 337.07M 2024-09
Sartorius EUR 181.2M 42.4M 2024-09
Sino Biopharmaceutical CNY 4.16B 1.02B 2024-06
Supernus Pharmaceuticals USD 49.15M 11.8M 2024-12
Tilray USD -101000 2.32M 2024-11
Zhangzhou Pientzehuang Pharmaceutical 1.13B 234.12M 2024-09



Xeris Pharmaceuticals - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Mar 2025.